Nugusse, who rides horse drawn carriages for a living in Ethiopia, successfully completed his tuberculosis (TB) treatment using a digital adherence technology (DAT), provided by the ASCENT project.

In this video, made in Ethiopia, Tsedale explains the advantages she experienced using a DAT, the medication sleeve/label, in comparison to DOT.

A tuberculosis survivor named Netsanet, a 35-year-old mother of three, explained her experience on the use of digital adherence technology for her treatment.

ASCENT Ethiopia conducted a review meeting to discuss project implementation and research progress and the transition plan for sustainability and scale-up.

ASCENT in Ethiopia conducted an orientation meeting on digital adherence technologies for civil society organization members to ensure community engagement activities.

ASCENT Ethiopia conducted a one-day review meeting in Bishoftu town Gold Mark Hotel for better implementation of the project.

Mehamed is a father of one daughter, husband and merchant of used clothes. He lives in Addis Ababa (Ethiopia) and was diagnosed with tuberculosis (TB) at the age of 27. Shortly after his diagnosis, he started his treatment supported by a smart pillbox provided by the ASCENT project, funded by Unitaid and led by KNCV Tuberculosis Foundation.

The Community Advisory Board (CAB) for the ASCENT project in Ethiopia was established to guard the safety and well-being of beneficiaries/study participants.

The ASCENT Ethiopia team held a randomization ceremony and successfully assigned health facilities to different study arms.